Your session is about to expire
← Back to Search
Antiseptic
1 for Catheterization
Phase 4
Waitlist Available
Led By Erik S. Thingvoll, MD
Research Sponsored by National Institute of Allergy and Infectious Diseases (NIAID)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Pivotal Trial
No Placebo-Only Group
Drug Has Already Been Approved
Summary
The purpose of this study is to prevent catheter-related infections in newborn infants admitted to the Neonatal Intensive Care Unit (NICU). This study will compare the effectiveness of daily chlorhexidine versus isopropyl alcohol in preventing the growth of microbes in catheters.
Eligible Conditions
- Catheterization
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Awards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
Chlorhexidien as the antibacterial agent used to cleanse the hub of neonatal central lines
Group II: 2Active Control1 Intervention
Isopropyl alcohol as the antibacterial agent used to cleanse the hub of neonatal central lines
Find a Location
Who is running the clinical trial?
National Institute of Allergy and Infectious Diseases (NIAID)Lead Sponsor
3,317 Previous Clinical Trials
5,547,646 Total Patients Enrolled
University of RochesterOTHER
866 Previous Clinical Trials
545,230 Total Patients Enrolled
Erik S. Thingvoll, MDPrincipal InvestigatorUniversity of Rochester
Share this study with friends
Copy Link
Messenger